# Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-analysis-of-metformin-dipeptidyl-peptidase-4-inhibitors/

## Facts

| Field | Value |
| --- | --- |
| Author Names | C.S. Kwon,Enrique Seoane‐Vazquez,Rosa Rodríguez-Monguió |
| Citations | 33 |
| DOI | 10.1186/s12913-018-2860-0 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmchealthservres.biomedcentral.com/track/pdf/10.1186/s12913-018-2860-0 |
| OpenAlex ID | https://openalex.org/W2788234401 |
| PMID | 29391064 |
| Type | article |
| Year | 2018 |

## Paper authors

- [C.S. Kwon](https://scholariq.org/researchers/c-s-kwon/)

## Paper journal

- [BMC Health Services Research](https://scholariq.org/journals/bmc-health-services-research/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.